Advertisement

Get Topic Updates

Share

Written by the OrganizedWisdom Team with as the reviewer. All original content is supervised by the The OrganizedWisdom Medical Review Team

medicalnewstoday.com

1 of 0

Resource Description:

Shire plc (LSE: SHP, NASDAQ: SHPGY), the global specialty biopharmaceutical company, has announced that it has received approval from the US Food and Drug Administration (FDA) for INTUNIV" (

« Back to the Intuniv Uses WisdomCard

Also Recommended Here:

Related Health Centers:

Advertisement